Pfizer
Candace Kaplan, CPA, currently serves as a Senior Accountant in Global Accounting, focusing on Corporate and US Accounting at Pfizer since November 2024. Prior to this role, Candace held various accounting positions, including Senior Accountant at PartnerCare from March 2023 to November 2024 and at Aspen Group, Inc. from June 2022 to March 2023. Candace also served as a Property Accounting Manager at Campus Advantage and worked as a Senior Accountant at JMJ Associates and KBI Biopharma. Earlier experience includes a role as an Internal Auditor at Office Depot and audit positions at CBIZ MHM, LLC. Candace completed a Master of Accountancy in Forensic Accounting and holds a Bachelor of Business Administration in Accounting, both from Florida Atlantic University. Candace's educational background also includes a High School Diploma from Leysin American School in Switzerland.
This person is not in any teams
This person is not in any offices
Pfizer
587 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.